Cantila, Felecidad L.

HRN: 25-78-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/13/2024
09/19/2024
IVTT
500 Mg
OD
Complicated Urinary Tract Infection
Waiting Final Action 

Indication:  EmpiricCulture-directed    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: